Hypertriglyceridemia is responsible for about ~10% of pancreatitis episodes seen in critical care. The management of this entity is highly variable, due to a lack of high-quality evidence. Approaches range from extremely aggressive (e.g. plasmapheresis) to more conservative therapy (e.g. subcutaneous insulin). This chapter attempts to unpack the physiology and evidence underlying this diagnosis, with the caveat that most questions remain without definitive answers.
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
The Podcast Episode
Want to Download the Episode?
Right Click Here and Choose Save-As
- IBCC – Revamped COVID chapter focusing on ICU & stepdown management - January 25, 2021
- IBCC chapter – Disseminated Intravascular Coagulation (DIC) - January 18, 2021
- PulmCrit- RCTs don't justify using convalescent plasma or antibody cocktails - January 14, 2021